Submitted by Anonymous (not verified) on 18 December 2025 - 10:46
Human medicines European public assessment report (EPAR): Breyanzi, lisocabtagene maraleucel, Date of authorisation: 04/04/2022, Revision: 11, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Breyanzi, lisocabtagene maraleucel, Date of authorisation: 04/04/2022, Revision: 11, Status: Authorised